De Witte Jan reported tax withholding involving 59.981 shares of RESMED INC at $234.11 for −$14.0k on Nov 11, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Director
DIR
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$14,042.15Shares × reported price
Shares traded
59.981ResMed Common Stock
Price per share
$234.11Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
4,201Direct
Trade date
Nov 11, 2026Tax withholding
Filed
Nov 13, 2026, 9:22 AM ET2-day reporting delay
Accession
0000943819-26-000100Code F · Transaction 400215
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −1.8%1w ago +0.7%1d ago −1.5%
Returns since7d30d90d180d1y

Footnotes in full

F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.